HealthcareServices

Venous Thromboembolism Global Forecast: Market to Scale Up to $3.19 Billion by 2030 at 5% CAGR

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the venous thromboembolism market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Venous Thromboembolism Market in 2026, and what figure is it projected to hit by 2030?

The market size for venous thromboembolism has consistently expanded in recent years. This market is projected to expand from $2.53 billion in 2025 to $2.63 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 3.9%. Several factors contributed to this historical growth, including a rise in the incidence of venous thromboembolism, an expanding aging population, a growing prevalence of sedentary lifestyles, enhanced clinical understanding of VTE risks, and the broadening of hospital-based thrombotic care services.

The venous thromboembolism market is projected to experience consistent expansion over the upcoming years, reaching a valuation of $3.2 billion by 2030, propelled by a compound annual growth rate (CAGR) of 5.0%. This anticipated market growth during the forecast period is primarily driven by several factors, including the increasing integration of personalized anticoagulant therapy, a rising preference for minimally invasive treatment solutions, the broadening of outpatient VTE care frameworks, heightened investments in cutting-edge diagnostic instruments, and an intensified emphasis on proactive thrombosis prevention and management. Key trends anticipated over the forecast horizon encompass the wider acceptance of novel oral anticoagulants, an escalating deployment of mechanical thrombectomy devices, a sharpened focus on timely diagnosis and effective risk stratification, the proliferation of home-based VTE management initiatives, and enhanced vigilance in monitoring anticoagulant therapy.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13001&type=smp

Which Drivers Are Affecting Market Participation In The Venous Thromboembolism Market?

The expansion of healthcare infrastructure is set to propel the growth of the venous thromboembolism market in the future. The healthcare industry is defined by the amalgamation and integration of economic system sectors that deliver products and services aimed at curing, preventing, rehabilitating, and providing palliative care for patients. This growth in the healthcare industry contributes to the establishment of institutional infrastructure, policies, practices, and educational initiatives necessary to support the implementation of VTE prevention protocols. For example, in May 2023, the American Health Care Association, a US-based nonprofit organization, noted that the number of hospitals in the US increased to 6,129 from 6,093 in 2022. Consequently, the expansion of the healthcare industry is a key factor driving the venous thromboembolism market’s growth.

What Segment Categories Are Covered In The Venous Thromboembolism Market?

The venous thromboembolism market covered in this report is segmented –

1) By Type: Deep Vein Thrombosis, Pulmonary Embolism, Other Types

2) By Treatment: Anti-Clotting Medications, Mechanical Devices, Thrombolytic Therapy, Other Treatment

3) By End Users: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:

1) By Deep Vein Thrombosis (DVT): Proximal DVT, Distal DVT, Asymptomatic DVT

2) By Pulmonary Embolism (PE): Acute PE, Chronic PE, Submassive PE

3) By Other Types: Thrombophlebitis, Superficial Vein Thrombosis, Post-Thrombotic Syndrome

What Industry Trends Are Transforming The Venous Thromboembolism Market?

Companies operating within the venous thromboembolism (VTE) market are concentrating on integrating advanced vascular-access sheath technology, such as laser-cut hypotube sheaths, to boost efficiency, safety, and procedural precision. This laser-cut hypotube sheath technology utilizes a thin-walled metal tube meticulously cut by a laser, resulting in a sheath that offers both flexibility and structural integrity. This design enables smooth navigation through blood vessels, provides stable support during catheter delivery, and facilitates improved hemostasis control during medical procedures. For example, in January 2025, Penumbra Inc., a US-based medical-device manufacturer, introduced the Element Vascular Access System. This laser-cut hypotube sheath, specifically designed for venous thromboembolism procedures, incorporates the HemoLock dual-valve system for accurate hemostasis control and features an atraumatic tip design along with 17 F MaxID sizing, ensuring smooth delivery and compatibility with large-bore thrombectomy catheters. The Element system enhances procedure efficiency, device trackability, and physician control, potentially leading to increased safety and better treatment outcomes in VTE interventions.

Which Key Players Are Driving Competition In The Venous Thromboembolism Market?

Major companies operating in the venous thromboembolism market are Pfizer Inc., Johnson and Johnson Limited, Merck and Co Inc, AbbVie Inc, Bayer AG, Novartis AG, Sanofi-Aventis LLC, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Eli Lilly and Co Ltd, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Company Limited, Portola Pharmaceuticals Inc, Viatris Inc, AstraZeneca PLC, Medtronic plc, Boston Scientific Corporation, Stryker Corporation, Abbott Laboratories, AngioDynamics Inc, Terumo Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/venous-thromboembolism-global-market-report

How Does The Venous Thromboembolism Market Perform Across Major Global Regions?

North America was the largest region in the venous thromboembolism market in 2025. The regions covered in the venous thromboembolism market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Venous Thromboembolism Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13001&type=smp

Browse Through More Reports Similar to the Global Venous Thromboembolism Market 2026, By The Business Research Company

Vascular Embolization Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report

Deep Vein Thrombosis Market Report 2026

https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report

Thrombophilia Market Report 2026

https://www.thebusinessresearchcompany.com/report/thrombophilia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795